Dr Reddys Laboratories (RDY) Receivables - Other (2017 - 2025)
Dr Reddys Laboratories has reported Receivables - Other over the past 9 years, most recently at $92384.3 for Q1 2025.
- For Q1 2025, Receivables - Other fell 84.34% year-over-year to $92384.3; the TTM value through Mar 2025 reached $92384.3, down 84.34%, while the annual FY2025 figure was $94652.4, 84.01% down from the prior year.
- Receivables - Other for Q1 2025 was $92384.3 at Dr Reddys Laboratories, down from $590035.9 in the prior quarter.
- Over five years, Receivables - Other peaked at $590035.9 in Q1 2024 and troughed at $12164.9 in Q1 2023.
- A 5-year average of $355028.6 and a median of $531962.9 in 2022 define the central range for Receivables - Other.
- Biggest five-year swings in Receivables - Other: tumbled 97.71% in 2023 and later skyrocketed 4750.33% in 2024.
- Year by year, Receivables - Other stood at $548595.0 in 2021, then fell by 3.03% to $531962.9 in 2022, then tumbled by 97.71% to $12164.9 in 2023, then soared by 4750.33% to $590035.9 in 2024, then crashed by 84.34% to $92384.3 in 2025.
- Business Quant data shows Receivables - Other for RDY at $92384.3 in Q1 2025, $590035.9 in Q1 2024, and $12164.9 in Q1 2023.